Oxford study supports AstraZeneca for third dose against Omicron
London: A third dose of AstraZeneca's Covid vaccine, named Covishield in India, produces similar neutralising antibody levels against Omicron as ...
Read moreLondon: A third dose of AstraZeneca's Covid vaccine, named Covishield in India, produces similar neutralising antibody levels against Omicron as ...
Read moreMumbai: Complacency towards following social distancing as a ‘social vaccine’ continues to high in India. This is happening even though ...
Read moreLondon: The hypermutated Omicron Covid variant, known to evade vaccine efficacy, cannot be deterred with two doses of Oxford-AstraZeneca or ...
Read moreLondon: Following up first doses of the AstraZeneca or Pfizer vaccines with second doses of the Moderna or Novavax jabs ...
Read moreNew Delhi: Russian Direct Investment Fund (RDIF) said Monday it has applied for the registration of 'Sputnik M', Covid-19 vaccine ...
Read moreLondon: While the Covid-19 crisis is not over yet with the new super mutant Omicron spreading to 38 countries, the ...
Read moreLondon: Amid calls for pushing booster doses against Covid-19 in view of the new super mutant variant Omicron that is ...
Read moreLondon: A single shot of an antibody treatment against Covid-19 developed by UK drug major AstraZeneca is 83 per cent ...
Read moreNew Delhi: The World Health Organisation is likely to grant emergency use approval to Bharat Biotech's Covaxin "within 24 hours", ...
Read moreNew Delhi: A rare nerve disorder that affects the feet, hands and limbs has been added to the list of ...
Read more